Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy

Mesial temporal lobe epilepsy is the most common type of focal epilepsy, imposing a significant burden on the health care system worldwide. Approximately one-third of patients with this disease who do not adequately respond to pharmacotherapy are considered drug-resistant subjects. Despite having so...

Full description

Bibliographic Details
Main Authors: Elena A. Filimonova, Anton A. Pashkov, Galina I. Moysak, Anastasia Y. Tropynina, Svetlana Y. Zhanaeva, Anna A. Shvaikovskaya, Anna A. Akopyan, Konstantin V. Danilenko, Lyubomir I. Aftanas, Maria A. Tikhonova, Jamil A. Rzaev
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1217702/full
_version_ 1797777456564797440
author Elena A. Filimonova
Elena A. Filimonova
Anton A. Pashkov
Anton A. Pashkov
Galina I. Moysak
Galina I. Moysak
Anastasia Y. Tropynina
Anastasia Y. Tropynina
Svetlana Y. Zhanaeva
Anna A. Shvaikovskaya
Anna A. Akopyan
Konstantin V. Danilenko
Lyubomir I. Aftanas
Lyubomir I. Aftanas
Maria A. Tikhonova
Jamil A. Rzaev
Jamil A. Rzaev
Jamil A. Rzaev
author_facet Elena A. Filimonova
Elena A. Filimonova
Anton A. Pashkov
Anton A. Pashkov
Galina I. Moysak
Galina I. Moysak
Anastasia Y. Tropynina
Anastasia Y. Tropynina
Svetlana Y. Zhanaeva
Anna A. Shvaikovskaya
Anna A. Akopyan
Konstantin V. Danilenko
Lyubomir I. Aftanas
Lyubomir I. Aftanas
Maria A. Tikhonova
Jamil A. Rzaev
Jamil A. Rzaev
Jamil A. Rzaev
author_sort Elena A. Filimonova
collection DOAJ
description Mesial temporal lobe epilepsy is the most common type of focal epilepsy, imposing a significant burden on the health care system worldwide. Approximately one-third of patients with this disease who do not adequately respond to pharmacotherapy are considered drug-resistant subjects. Despite having some clues of how such epileptic activity and resistance to therapy emerge, coming mainly from preclinical models, we still witness a scarcity of human data. To narrow this gap, in this study, we aimed to estimate the relationship between hippocampal and serum levels of brain-derived neurotrophic factor (BDNF), one of the main and most widely studied neurotrophins, and hippocampal subfield volumes in patients with drug-resistant mesial temporal epilepsy undergoing neurosurgical treatment. We found that hippocampal (but not serum) BDNF levels were negatively correlated with the contralateral volumes of the CA1 and CA4 subfields, presubiculum, subiculum, dentate gyrus, and molecular layer of the hippocampus. Taken together, these findings are generally in accordance with existing data, arguing for a proepileptic nature of BDNF effects in the hippocampus and related brain structures.
first_indexed 2024-03-12T23:04:12Z
format Article
id doaj.art-ec768bc59f5144f89d8be5a97ff05889
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-03-12T23:04:12Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-ec768bc59f5144f89d8be5a97ff058892023-07-19T06:15:54ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-07-011710.3389/fnins.2023.12177021217702Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsyElena A. Filimonova0Elena A. Filimonova1Anton A. Pashkov2Anton A. Pashkov3Galina I. Moysak4Galina I. Moysak5Anastasia Y. Tropynina6Anastasia Y. Tropynina7Svetlana Y. Zhanaeva8Anna A. Shvaikovskaya9Anna A. Akopyan10Konstantin V. Danilenko11Lyubomir I. Aftanas12Lyubomir I. Aftanas13Maria A. Tikhonova14Jamil A. Rzaev15Jamil A. Rzaev16Jamil A. Rzaev17FSBI "Federal Center of Neurosurgery", Novosibirsk, RussiaDepartment of Neurosurgery, Novosibirsk State Medical University, Novosibirsk, RussiaFSBI "Federal Center of Neurosurgery", Novosibirsk, RussiaBiomedical School, South Ural State University, Chelyabinsk, RussiaFSBI "Federal Center of Neurosurgery", Novosibirsk, RussiaDepartment of Neuroscience, Institute of Medicine and Psychology, Novosibirsk State University, Novosibirsk, RussiaDepartment of Neuroscience, Institute of Medicine and Psychology, Novosibirsk State University, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaDepartment of Neuroscience, Institute of Medicine and Psychology, Novosibirsk State University, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaScientific Research Institute of Neurosciences and Medicine, Novosibirsk, RussiaFSBI "Federal Center of Neurosurgery", Novosibirsk, RussiaDepartment of Neurosurgery, Novosibirsk State Medical University, Novosibirsk, RussiaDepartment of Neuroscience, Institute of Medicine and Psychology, Novosibirsk State University, Novosibirsk, RussiaMesial temporal lobe epilepsy is the most common type of focal epilepsy, imposing a significant burden on the health care system worldwide. Approximately one-third of patients with this disease who do not adequately respond to pharmacotherapy are considered drug-resistant subjects. Despite having some clues of how such epileptic activity and resistance to therapy emerge, coming mainly from preclinical models, we still witness a scarcity of human data. To narrow this gap, in this study, we aimed to estimate the relationship between hippocampal and serum levels of brain-derived neurotrophic factor (BDNF), one of the main and most widely studied neurotrophins, and hippocampal subfield volumes in patients with drug-resistant mesial temporal epilepsy undergoing neurosurgical treatment. We found that hippocampal (but not serum) BDNF levels were negatively correlated with the contralateral volumes of the CA1 and CA4 subfields, presubiculum, subiculum, dentate gyrus, and molecular layer of the hippocampus. Taken together, these findings are generally in accordance with existing data, arguing for a proepileptic nature of BDNF effects in the hippocampus and related brain structures.https://www.frontiersin.org/articles/10.3389/fnins.2023.1217702/fullmesial temporal lobe epilepsydrug-resistant epilepsyBDNFMR morphometryFreeSurferhippocampus
spellingShingle Elena A. Filimonova
Elena A. Filimonova
Anton A. Pashkov
Anton A. Pashkov
Galina I. Moysak
Galina I. Moysak
Anastasia Y. Tropynina
Anastasia Y. Tropynina
Svetlana Y. Zhanaeva
Anna A. Shvaikovskaya
Anna A. Akopyan
Konstantin V. Danilenko
Lyubomir I. Aftanas
Lyubomir I. Aftanas
Maria A. Tikhonova
Jamil A. Rzaev
Jamil A. Rzaev
Jamil A. Rzaev
Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
Frontiers in Neuroscience
mesial temporal lobe epilepsy
drug-resistant epilepsy
BDNF
MR morphometry
FreeSurfer
hippocampus
title Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
title_full Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
title_fullStr Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
title_full_unstemmed Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
title_short Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy
title_sort brain but not serum bdnf levels are associated with structural alterations in the hippocampal regions in patients with drug resistant mesial temporal lobe epilepsy
topic mesial temporal lobe epilepsy
drug-resistant epilepsy
BDNF
MR morphometry
FreeSurfer
hippocampus
url https://www.frontiersin.org/articles/10.3389/fnins.2023.1217702/full
work_keys_str_mv AT elenaafilimonova brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT elenaafilimonova brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT antonapashkov brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT antonapashkov brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT galinaimoysak brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT galinaimoysak brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT anastasiaytropynina brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT anastasiaytropynina brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT svetlanayzhanaeva brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT annaashvaikovskaya brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT annaaakopyan brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT konstantinvdanilenko brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT lyubomiriaftanas brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT lyubomiriaftanas brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT mariaatikhonova brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT jamilarzaev brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT jamilarzaev brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy
AT jamilarzaev brainbutnotserumbdnflevelsareassociatedwithstructuralalterationsinthehippocampalregionsinpatientswithdrugresistantmesialtemporallobeepilepsy